Rockwell Medical Reports Record Net Sales and First Full-Year Adjusted EBITDA Profitability in 2024

ROCKWELL MEDICAL, INC.

Record net sales of $101.5M in 2024, a 21% increase over 2023.
Record gross profit of $17.5M in 2024, a 101% increase over 2023.
Full-year adjusted EBITDA reached $5.2M, first time profitable on that basis.
Net loss improved 94% to $0.5M in 2024 from $8.4M in 2023.
Largest customer transitioning away; expects ~$34M revenue loss in 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.